The Centre for Drug Research (CIM) began its activities in 1983, in collaboration with the Clinical Pharmacology Department of the HSCSP and the Pharmacology and Therapeutics Department of the Autonomous University of Barcelona (UAB).
The CIM conducts clinical trials with drugs and clinical research in two areas:
Evaluation of the effects of psychotropic drugs and other substances active in the central nervous system on the sleep-wake cycle:Studies of effects during wakefulness (behavioural safety).
To carry out these functions two different areas are distinguished:
Further information: CIM Sant Pau Dossier
The Centre for Drug Research (CIM) began its activities in 1983, in collaboration with the Clinical Pharmacology Department of the HSCSP and the Pharmacology and Therapeutics Department of the Autonomous University of Barcelona (UAB).
The CIM conducts clinical trials with drugs and clinical research in two areas:
Evaluation of the effects of psychotropic drugs and other substances active in the central nervous system on the sleep-wake cycle:Studies of effects during wakefulness (behavioural safety).
To carry out these functions two different areas are distinguished:
Rosa M. Antonijoan
rantonijoana@santpau.cat
Mª Rosa Ballester
Jimena Coimbra
Joan Martínez
Pol Molina Perelló
Montserrat Puntes
Sandra Giménez
Maite Garrido
David Martínez
Maribel Martínez
Marta Castillo
Judit Claramunt
Sara Mora
Susana Clos
Sonia Coma
Consuelo García
Pura Martínez
Ignasi Gich
Mª Ángeles Funes
Ana Gomis
Esteve Mercader
A clinical trial is research conducted in humans that aims to determine or verify the safety and/or efficacy of one or more drugs. Most clinical trials conducted at the CIM are aimed at ensuring the drug’s safety profile (adverse reactions) and at studying pharmacokinetics (absorption, distribution, metabolism and excretion). All studies must be approved by a clinical research ethics committee and must be authorized by the AEMPS. All personal data and medical results are treated in the strictest of confidence. Participation in a clinical trial is voluntary and even after granting consent, participants may withdraw at any time. At the end of the study, participants are compensated for their time.
In general, eligible to participate in CIM clinical trials are men and women of age, in possession of their mental faculties, non-smokers, non-abusers of alcohol or of recreational drugs, not in receipt of prescription drugs and who have not recently given blood or participated in another study of an investigational drug. Persons with a history of drug allergies may not participate. Women participants should avoid getting pregnant during the study by using a non-hormonal contraceptive method of proven efficacy.
Persons who wish to participate in a clinical trial must sign an informed consent that explains the design and purposes of the trial, possible risks that may arise from participation and the right to withdraw at any time.
Persons interested in participating in a clinical trial will find information below on upcoming information sessions:
